claim: a sars-cov-2 vaccine candidate would likely match all currently circulating variants
evidence_1: here we analyzed sars-cov-2 sequences sampled since the beginning of the pandemic and found that mutations were rare, indicating that potential vaccine candidates should cover all circulating variants.